H.U. Group Holdings, Inc.
Research H.U. Group Holdings, Inc. (4544.T) on Bullrun: market cap JPY 200.89B, P/E 21.7, dividend yield 3.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4544.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyJPY
- Market capJPY 200.89B
- P/E21.7
- Dividend yield3.4%
- Financial periodFY2026
- RevenueJPY 247.36B
- Revenue growth1.8%
- Net incomeJPY 6.82B
- Free cash flowJPY 16.70B
- Gross margin28.9%
Valuation Snapshot
latest market cap is JPY 200.89B; P/E is 21.7; dividend yield is 3.4%.
Peer valuation comparison
Latest P/E is 21.74x versus a Healthcare sector median of 21.69x.
Latest dividend yield is 3.37% versus a Healthcare sector median of 2.41% (39.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 247.36B | JPY 6.82B | JPY 16.70B | 28.9% | 121.52 | JPY 48.11B | JPY 74.33B | JPY 137.41B |
| FY2025 | JPY 243.03B | JPY 2.76B | JPY 11.65B | 27.7% | 48.6 | JPY 40.89B | JPY 86.65B | JPY 137.11B |
| FY2024 | JPY 236.95B | -JPY 7.55B | -JPY 1.01B | 26.7% | -132.77 | JPY 39.95B | JPY 81.95B | JPY 142.51B |
| FY2023 | JPY 260.91B | JPY 15.68B | JPY 10.85B | 34.5% | 275.5 | JPY 44.19B | JPY 77.16B | JPY 150.05B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 200.89B | 21.7 | 3.4% | 125 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 125 JPY, yield 3.4%.
| Year | Dividends/share |
|---|---|
| FY2026 | 125 JPY |
| FY2025 | 125 JPY |
| FY2024 | 125 JPY |
| FY2023 | 125 JPY |
About H.U. Group Holdings, Inc.
H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally. The Lab Testing and Its Related Services segment provides general testing services to medical institutions that include esoteric testing, such as genetic and oncology testing; diagnostics-related tests for cancer treatment; omics analysis comprising whole genome sequencing (WGS) and proteome analysis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is H.U. Group Holdings, Inc.'s market cap?
H.U. Group Holdings, Inc.'s market capitalization is JPY 200.89B.
What is H.U. Group Holdings, Inc.'s P/E ratio?
H.U. Group Holdings, Inc.'s price-to-earnings (P/E) ratio is 21.7.
Does H.U. Group Holdings, Inc. pay a dividend?
H.U. Group Holdings, Inc. has a dividend yield of 3.4%.
What does H.U. Group Holdings, Inc. do?
H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally.